NEW YORK (GenomeWeb) – BioMérieux reported today that its third quarter revenues grew 7 percent year over year driven in part by strong growth in its molecular biology clinical applications.

For the three months ended Sept. 30, the Marcy l'Étoile, France-based in vitro diagnostics firm recorded revenues of €579.7 million ($666.3 million) compared to €540.0 million in the year-ago period. Organic growth, at constant exchange rates and scope of consolidation, was 9 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.